Production of a Cost-Effective, TMV-Based Rabies Vaccine through Recombinant DNA Technology
Infectious diseases remain a significant cause of human deaths, as approximately 15 million deaths were attributed to infectious diseases in 2010 (Dye, 2014). One such disease is rabies, which causes around 59,000 human deaths worldwide annually according to some estimates (Kessels et al., 2017). Ho...
Main Author: | |
---|---|
Format: | Others |
Published: |
Scholarship @ Claremont
2018
|
Subjects: | |
Online Access: | http://scholarship.claremont.edu/cmc_theses/1816 http://scholarship.claremont.edu/cgi/viewcontent.cgi?article=2797&context=cmc_theses |